BioAdaptives, Inc.
BDPT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -55.6% | 66.3% | -13.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 31.8% | 37.9% | 41.5% | 51.1% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | -4,595.1% | -1,823.9% | -3,167.2% | -3,256.5% |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -7,096.1% | -2,492.6% | -5,216.6% | -5,309.5% |
| EPS Diluted | -0.11 | -0.12 | -1.27 | -4.67 |
| % Growth | 8.3% | 90.6% | 72.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |